IP Verse

Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment - EP2207597

PATENT ANALYSIS

Patent Details

Grant Date
Feb 19, 2020
Company
LAJOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
Oppositions

EUROPEAN OPPOSITIONS LIMITED

More patents of Lajolla Institute For Allergy And Immunology

EP2207597

Want to monitor this patent?

Feel free to send us a message here and we will get back to you